China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294) Margin Operasi

Q: Berapakah harga China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294)

Harga China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294) adalah $2.16

Q: Apakah topi pasaran China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294)

Cap pasaran China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294) adalah $1.09B

Established in 1993 and headquartered in Fuzhou, China, China Resources Boya Bio-pharmaceutical Group Co., Ltd. (formerly Boya Bio-pharmaceutical Group Co., Ltd.) is a comprehensive pharmaceutical enterprise operating across China. The company is engaged in the research, development, production, and sale of a diverse portfolio, primarily focusing on blood products, diabetes medications, and various biochemical and chemical pharmaceuticals. Its extensive range of blood-derived products includes human fibrinogen, human albumin, intravenous human immunoglobulin, rabies immunoglobulin, hepatitis B human immunoglobulin, and freeze-dried intravenous human immunoglobulin. For diabetes management, the company offers metformin hydrochloride (both tablets and enteric-coated versions), pioglitazone hydrochloride dispersible tablets, glimepiride tablets, and calcium dobesilate capsules. Additionally, it produces specialized injections such as compound osteotide, oxytocin, and heparin sodium, which are utilized across numerous medical fields, including general medicine, hepatitis treatment, gynecology, and immunomodulatory applications.

Tahun	Margin Operasi	Ubah
Tidak cukup data untuk tarikh yang disediakan.

Tahun

Margin Operasi

Ubah

Tidak cukup data untuk tarikh yang disediakan.

Syarikat	Margin Operasi	Perbezaan Margin Operasi	Negara
Vertex Pharmaceuticals Incorporated VRTX.US	38.59%	-	US
Argenx SE ARGX.US	28.81%	-	NL
CSL Limited CSL.AX	25.72%	-	AU
Moderna, Inc. MRNA.US	-149.01%	-	US
Lonza Group AG LONN.SW	0.00%	-	CH

Syarikat

Margin Operasi

Perbezaan Margin Operasi

Negara